Thomas Petri

1.0k citations
24 papers · 867 indexed · h-index 15

Thomas Petri

24 papers receiving 810 citations

Peers

Thomas Petri
Comparison fields: 5 of 90
  • Cancer Research 364
  • Hematology 225
  • Immunology and Allergy 108
  • Reproductive Medicine 66
  • Physiology 33
Replace Annukka Paju with:
Annukka Paju Finland
S J Degen United States
J P Witty United States
Nina Cimerman Slovenia
F Paolucci France
Akiko Spindle United States
Baikun Wang United States
Martine J. van Vugt Netherlands
Eliezer Gorelik United States
Édouard F. Potworowski Canada
Thomas Petri relative to Annukka Paju Finland Annukka Paju's profile →
Citations per field
00.5×6.6×
Annukka Paju · 1×
Citations per year

Countries citing papers authored by Thomas Petri

Since Specialization
Citations

This map shows the geographic impact of Thomas Petri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Petri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Petri more than expected).

Fields of papers citing papers by Thomas Petri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Petri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Petri. The network helps show where Thomas Petri may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Petri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Petri Line = papers co-authored together Thomas Petri links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20155
2 201412
3 20137
4 2000100
5 200010
6 19997
7 19988
8 199596
9 199518
10 199513
11 199457
12 199386
13 199234
14 198219
15 198119
16 198015
17 197917
18 197919
19 197917
20 197910

About Thomas Petri

Thomas Petri is a scholar working on Immunology and Allergy, Family Practice, Cancer Research, Epidemiology and Hematology, having authored 24 papers that have together received 867 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (8 papers), Protease and Inhibitor Mechanisms (6 papers), Blood properties and coagulation (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Cell Adhesion Molecules Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), interferon and immune responses (2 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Cancer Research (364 citations), Hematology (225 citations), Immunology and Allergy (108 citations), Reproductive Medicine (66 citations) and Physiology (33 citations). Thomas Petri has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Wolf‐Dieter Schleuning, Inna Dumler, H. Meier-Ewert, Michael Ploug, Niels Behrendt, Ettore Appella, Lene Nielsen, Keld Danø, Ebbe Rønne and Francesco Blasi. Their work appears in journals such as FEBS Letters, BMC Pulmonary Medicine, Apmis, Journal of General Virology and Archives of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026